期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 208, 期 13, 页码 2633-2640出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20102575
关键词
-
资金
- National Institutes of Health (NIH) [DK51362, DK44319, DK53056, DK088199, AI066897]
- Harvard Digestive Diseases Center (NIH) [P30DK034854]
- High Pointe Foundation
- Israel-U.S. Binational Research Award
- Canadian Institutes of Health Research
- Crohn's & Colitis Foundation of America
Although carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) has been viewed as a tumor suppressor, increasing clinical evidence shows that high levels of CEACAM1 expression on tumors correlates with poor prognosis and high risk of metastasis. Here, we examined the consequences of CEACAM1 expression on tumor cells. We show that tumor cell-associated CEACAM1 causes intracellular retention of various NKG2D ligands in mouse and human tumor cells. CEACAM1-silenced tumor cells expressed more cell surface NKG2D ligands and exhibited greater sensitivity to natural killer cell-mediated cytolysis in vitro and rejection in vivo. Our studies reveal a novel mechanism through which CEACAM1-bearing tumor cells may escape immune-surveillance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据